ArticleHypertension research : official journal of the Japanese Society of Hypertension2022
Latest hypertension research to inform clinical practice in Asia.
Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 35 citations in OpenAlex.
- Practical prediction of 24-hour urinary sodium excretion in young people: a new formula derived from Tanaka and INTERSALT formulas.Hypertension research : official journal of the Japanese Society of Hypertension · 2026Article
- Exploring the social and behavioral barriers to hypertension self-care among indonesian adults: a qualitative study based on the theory of planned behavior.BMC public health · 2026Article
- Effectiveness of nurse-led hypertension self-management interventions: A mixed-methods systematic review and meta-analysis.International journal of nursing sciences · 2026Review
- Cascade of care for type 2 diabetes mellitus and hypertension in rural Bangladesh: sub-regional mapping of gaps in care.BMJ public health · 2026Article
- Prevalence and Determinants of Abnormal Ambulatory Blood Pressure and Circadian Patterns Among Adults in Ido Ekiti, Nigeria: A Community-Based Study.International journal of hypertension · 2026Article
- 2024 Thai guidelines on the treatment of hypertension.Asian biomedicine : research, reviews and news · 2025Article
- Hypertension Research global initiatives 2025 added new themes-"implementation hypertension" and "morning hypertension".Hypertension research : official journal of the Japanese Society of Hypertension · 2025Article
- The WHO Global report 2023 on hypertension warning the emerging hypertension burden in globe and its treatment strategy.Hypertension research : official journal of the Japanese Society of Hypertension · 2024Article
- A tryst of 'blood pressure control- sex- comorbidities': the odyssey of basic public health services in Yunnan in quest for truth.BMC public health · 2024Article
- Five special focuses of Hypertension Research: digital hypertension, home blood pressure-centered approach, renal denervation, Asians, for guidelines.Hypertension research : official journal of the Japanese Society of Hypertension · 2023Article
- Digital hypertension towards to the anticipation medicine.Hypertension research : official journal of the Japanese Society of Hypertension · 2023Review
- Uncontrolled hypertension: the greatest challenge and perspectives in Asia.Hypertension research : official journal of the Japanese Society of Hypertension · 2022Article
- The first software as medical device of evidence-based hypertension digital therapeutics for clinical practice.Hypertension research : official journal of the Japanese Society of Hypertension · 2022Review
- The HOPE Asia Network activity 2022: Towards better hypertension management in Asia.Journal of clinical hypertension (Greenwich, Conn.) · 2022Article
- Long-term blood pressure lowering effect of renal denervation and its patient preference, salt intake, and stroke in Asia.Hypertension research : official journal of the Japanese Society of Hypertension · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite the challenges associated with the coronavirus pandemic, the last 2 years have been active periods for hypertension research and initiatives in Asia. There are new hypertension guidelines from the World Health Organization that can be interpreted and applied locally. This is also the case for data from the latest Blood Pressure Lowering Treatment Trialists' Collaboration meta-analysis, which showed that greater reductions in systolic blood pressure (BP) are associated with lower risks of cardiovascular events. The randomized controlled Strategy of Blood Pressure Intervention in the Elderly Hypertensive study and the Salt Substitute and Stroke Study provide local data to inform practice. Other initiatives to help reduce high salt intake in Asia are also underway. Both drug-resistant and nocturnal hypertension are appropriate areas of focus in Asia, and there are an increasing number of pharmacological and non-pharmacological treatment options for these conditions. Digital therapeutics to promote uptake and implementation of lifestyle interventions are showing promise, and other digital-based strategies such as telemedicine, wearable BP monitors to detect beat-by-beat BP and artificial intelligence will no doubt become integral parts of future strategies to reduce the burden of hypertension and hypertension-related disease. A number of initiatives from the Hypertension Cardiovascular Outcome Prevention and Evidence in Asia Network and Japanese Society of hypertension are underway, and there is good reason for optimism regarding the ongoing and future management of hypertension in Asia based on these and the active research activities in the region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.